These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16984221)

  • 1. The HIV landscape in a managed care environment: current challenges and potential solutions.
    Chao SH
    J Manag Care Pharm; 2006 Sep; 12(7 Suppl B):S2-5. PubMed ID: 16984221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of managed care on access to highly active antiretroviral therapy and on outcomes among Medicaid beneficiaries with AIDS.
    Zingmond DS; Ettner SL; Cunningham WE
    Med Care Res Rev; 2007 Feb; 64(1):66-82. PubMed ID: 17213458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based health benefits management: strategies to optimize antiretroviral medication adherence and outcomes in HIV/AIDS.
    Zabinski RA
    J Manag Care Pharm; 2006 Sep; 12(7 Suppl B):S12-6. PubMed ID: 16984223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of highly active antiretroviral therapy on incident AIDS using calendar period as an instrumental variable.
    Cain LE; Cole SR; Greenland S; Brown TT; Chmiel JS; Kingsley L; Detels R
    Am J Epidemiol; 2009 May; 169(9):1124-32. PubMed ID: 19318615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living long-term with HIV/AIDS: exploring impact in psychosocial and vocational domains.
    Vetter CJ; Donnelly JP
    Work; 2006; 27(3):277-86. PubMed ID: 17006004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AIDS dilemma: drug diseases blamed on a passenger virus.
    Duesberg P; Rasnick D
    Genetica; 1998; 104(2):85-132. PubMed ID: 10220905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Housing status and the health of people living with HIV/AIDS.
    Milloy MJ; Marshall BD; Montaner J; Wood E
    Curr HIV/AIDS Rep; 2012 Dec; 9(4):364-74. PubMed ID: 22968432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing trends in clinical AIDS presentations and survival among HIV-1-infected women.
    Charurat M; Blattner W; Hershow R; Buck A; Zorrilla CD; Watts DH; Paul M; Landesman S; Adeniyi-Jones S; Tuomala R;
    J Womens Health (Larchmt); 2004; 13(6):719-30. PubMed ID: 15333287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of death and factors associated with early death among human immunodeficiency virus (HIV)-infected persons in Singapore: pre-highly active antiretroviral therapy (HAART) and Peri-HAART.
    Chow A; Tey J; Win MK; Leo YS
    Ann Acad Med Singap; 2012 Dec; 41(12):563-70. PubMed ID: 23303113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease.
    Anastos K; Barrón Y; Miotti P; Weiser B; Young M; Hessol N; Greenblatt RM; Cohen M; Augenbraun M; Levine A; Muñoz A;
    Arch Intern Med; 2002 Sep; 162(17):1973-80. PubMed ID: 12230420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus (HIV) in America, 1981 to 1997: epidemiologic and therapeutic considerations.
    Reiter GS
    Semin Ultrasound CT MR; 1998 Apr; 19(2):122-7. PubMed ID: 9567317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.
    Smith DK; Gardner LI; Phelps R; Hamburger ME; Carpenter C; Klein RS; Rompalo A; Schuman P; Holmberg SD;
    J Urban Health; 2003 Dec; 80(4):676-88. PubMed ID: 14709715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful HIV treatment: lessons learned.
    Cohen CJ
    J Manag Care Pharm; 2006 Sep; 12(7 Suppl B):S6-11. PubMed ID: 16984222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV, tobacco use, and poverty: a potential cause of disparities in health status by race and socioeconomic status.
    Sowah LA; Busse S; Amoroso A
    J Health Care Poor Underserved; 2013 Aug; 24(3):1215-25. PubMed ID: 23974392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
    Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
    Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapy.
    Westreich D; Maskew M; Evans D; Firnhaber C; Majuba P; Sanne I
    PLoS One; 2013; 8(3):e58117. PubMed ID: 23520489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.
    Tran SD; Williams AB; Truong HT; Do NH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):283-7. PubMed ID: 9495230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of death in hospitalised HIV-infected patients at a National Referral Centre in Singapore: a retrospective review from 2008 to 2010.
    Wong CS; Lo FA; Cavailler P; Ng OT; Lee CC; Leo YS; Chua AC
    Ann Acad Med Singap; 2012 Dec; 41(12):571-6. PubMed ID: 23303114
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.